Google+ Badge

Tuesday, April 14, 2015

Cancer Research:Nanoparticles stimulate antitumor response ♦ Risk of developing pancreatic cancer ♦ Delivering drug to an entire tumor

Nanoparticles at specific temperature stimulate antitumor response Researchers have identified the precise temperature that results in a distinct body-wide antitumor immune response that resists metastatic disease.
Anti-cancer therapy delivering drug to an entire tumor developed To treat inoperable tumors, anti-cancer medicine is commonly used. However, efficient drug delivery to tumor cells is often difficult, treating an entire tumor with drugs even more so. A new anti-cancer nanotechnology has been developed by researchers that delivers anti-cancer drugs uniformly to an entire tumor
Melanoma's 'safe haven' targeted for shut-down Melanoma cells become drug resistant by using surrounding healthy cells to provide a ‘safe haven’ from treatment, according to new research. So even if some cancer cells are destroyed, the protected cancer cells may survive -- and the disease can recur in a form that is untreatable. Now scientists are focusing on these 'safe havens'.
Researchers identify drug target for the first precision cancer therapy Cancerous tumors have the ability to evade targeted therapies by activating alternative pathways. Tumors also contain cancer stem cells, believed responsible for metastasis and drug resistance. Now scientists have identified a drug target that addresses both of these challenges
Identifying patients most at risk of developing pancreatic cancer When people learn they have a lesion in their pancreas that could become pancreatic cancer, they often request frequent CT scans and biopsies, or surgery. Often the lesion is nothing to worry about. A team of international physicians has developed a profile of the patient most at risk of developing lesions that are most likely to develop into cancer

No comments:

Post a Comment